MedPath

Psychoeducational Intervention for Patients With Hepatocellular Carcinoma

Not Applicable
Recruiting
Conditions
Hepatocellular Carcinoma
Cirrhosis
Interventions
Behavioral: HARMONY
Other: Enhanced usual care
Registration Number
NCT06541990
Lead Sponsor
Massachusetts General Hospital
Brief Summary

This study aims to refine and pilot test HARMONY, a psychoeducational intervention for patients with newly diagnosed hepatocellular carcinoma (HCC).

Detailed Description

There are two parts of this study. Study Part 1 is an open pilot study to refine HARMONY prior to larger-scale testing in a randomized controlled trial (RCT) setting. Study Part 1 is purely descriptive, as the investigators will use the data to refine HARMONY before proceeding to Study Part 2.

Study Part 2 is a pilot RCT to assess the feasibility and acceptability of conducting a randomized trial of HARMONY versus enhanced usual care. Participants will complete a baseline survey and then be randomized to HARMONY versus enhanced usual care (a supportive care resource guide). This record reflects the clinical trial component (Study Part 2), as feasibility and acceptability outcomes will be collected for this phase only.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Age ≥18 years
  • New diagnosis of HCC within the last three months
  • Clinical, radiographic, and/or pathologic diagnosis of concomitant cirrhosis
  • Ability to complete study procedures English
Exclusion Criteria
  • Significant uncontrolled hepatic encephalopathy
  • Cognitive impairment, or psychiatric disorder which will interfere with study participation
  • Patients near the end of life for whom hospice is recommended

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HARMONYHARMONYHARMONY is a psychoeducational intervention that consists of five one-on-one coaching sessions and a structured session workbook.
Enhanced usual careEnhanced usual careThe enhanced usual care condition consists of a curated list of supportive care services for patients with HCC.
Primary Outcome Measures
NameTimeMethod
Feasibility: retention rate12 weeks

≥50% retention over the 12-week study

Feasibility: enrollment rate12 weeks

≥50% enrollment among consecutive eligible patients

Secondary Outcome Measures
NameTimeMethod
Acceptability12 weeks

≥75% of patients reporting Client Satisfaction Questionnaire-8 scores above the midpoint score of 20 on a scale from 8-32 (higher scores indicate higher satisfaction)

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath